Ceres Acquisition Corp.
CERAF
Other OTC9.98
USD
- -
- -
ISIN
CA1567341054
CUSIP
156734105
Return %
Stock
S&P500
1Y
0.15
26.53
3Y
-2.21
76.60
5Y
-2.21
80.11
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Joe Crouthers
- Sector
- Financial Services
- Industry
- Shell Companies
- Address
- 1925 Century Park East Los Angeles CA United States of America 90067
- IPO Date
- Feb 24, 2021
- Website
- ceresacquisition.com
- Similar Companies
- Business
- Ceres Acquisition Corp. (CERAF) is a special purpose acquisition corporation formed for the purpose of effecting an acquisition of one or more businesses or assets through a merger, amalgamation, arrangement, share exchange, asset acquisition, share purchase, reorganization, or similar business combination. The company focuses on identifying and evaluating opportunities for a qualifying transaction, with an initial target emphasis on businesses in the cannabis and related health and wellness industries, though not limited to any particular industry or geographic region. Incorporated under the laws of the Province of British Columbia, Canada, in 2020, Ceres Acquisition Corp. maintains its principal address at 1925 Century Park East, Suite 1700, Los Angeles, California, United States. As a blank-check company, it currently holds cash proceeds from its initial public offering in trust, intended solely to fund a business combination or return capital to shareholders upon completion of its permitted timeline or redemption. In early 2021, the company announced a proposed business combination with SH Parent, Inc. (operating as Parallel), an Atlanta-based multi-state cannabis operator, at an implied enterprise value of US$1.884 billion, supported by a US$225 million PIPE investment; however, the parties mutually agreed to terminate the agreement later that year. Ceres subsequently extended its timeline for a qualifying transaction to December 2022, but following significant shareholder redemptions, the board opted not to pursue further extensions amid challenging market conditions. In December 2022, the company announced the final redemption of all outstanding Class A restricted voting shares at approximately US$10.00045 per share and proceeded with winding up operations, delisting from the Neo Exchange and OTCQX markets shortly thereafter. No active products, services, or ongoing operations remain post-liquidation, with prior activities centered exclusively on SPAC-related merger pursuits.
Ceres Acquisition Corp. Releases Letter to Shareholders
Ceres Acquisition Corp. Announces the Mutually Agreed Termination of Its Business Combination Agreement With SH Parent, Inc.
3 Cannabis SPACs Hoping to Get High
Parallel Announces Opening of Its First goodblend™ Retail Store in Pennsylvania
Ceres Acquisition Corp. Reports First Quarter 2021 Financial Results
Parallel: Overlooked Cannabis MSO SPAC
Ceres Acquisition Corp. Reports Fourth Quarter and Fiscal 2020 Financial Results
OTC Markets Group Welcomes Ceres Acquisition Corp. to OTCQX